Welcome to the Diamond Retailer Breakfast! Ever wonder what goes on at these regular-fans-can’t-get-into-panels? Wonder. No. More.
Before heading into the presentation, I had a chance to sit down with a few retailers over eggs, bacon, sausage and much-needed coffee.
“What do you think of the breakfast?”
“Well, at least it didn’t arrive late or damaged.”
From England to Ohio, Marvel sales are in decline. One British shop owner said he’s been a Marvel shop for over 20 years, but his Marvel sales are at their lowest that he can remember. Another retailer, from Ohio, had a similar story. He described his clientele as “families who work in coal mines. These are the people who voted for Trump. They don’t want to be preached to by their comics.” He said his Marvel sales have all shifted to DC and Image. I asked him which DC titles were selling well now, besides Batman. “Surprisingly, Super Sons. But think about it. It’s two kids with superpowers who are friends.” He said that Superman is the title with the most improving sales month to month. The British retailer was shocked by this. But Ohio continued, saying, “Every month since Rebirth started I’m upping my order on Superman.”
Having our fill of coffee and bacon and coffee, we headed into the Diamond presentation.
Diamond is currently rolling out two new programs to its retailer partners.
New To Order – This online tool will allow retailers to order merchandise ahead of it showing up in Previews. This will mainly be for merchandise that is showing up in mass market stores.
Updating Comic Suite – 25% of stores in US and Canada are using point of sale software now. Diamond is updating their POS, Comics Suite. To be honest, I was surprised that the number was only 25%, but that may be from living in the New York City comic store bubble.
A few publishers were on hand to present to the retailers in attendance.
Billy Henehan writes for The Beat. When he’s not writing for The Beat, he writes silly Game of Thrones recaps for Tuesday Night Movies and co-hosts the Run Chat podcast.